We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$241M
AUM Growth
-$120M
Cap. Flow
-$12M
Cap. Flow %
-5%
Top 10 Hldgs %
81.75%
Holding
117
New
44
Increased
16
Reduced
22
Closed
31

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$3.34M
2
ENLV icon
Enlivex Ltd
ENLV
+$3.28M
3
BXRX
Baudax Bio, Inc. Common Stock
BXRX
+$2.52M
4
NOVN
Novan, Inc. Common Stock
NOVN
+$2.52M
5
OTLK icon
Outlook Therapeutics
OTLK
+$2.36M

Top Sells

Rank Stock Value
1
TRAW icon
Traws Pharma
TRAW
+$3.35M
2
GLD icon
SPDR Gold Trust
GLD
+$2.92M
3
HIND
Vyome Holdings
HIND
+$1.31M
4
GNPX icon
Genprex
GNPX
+$1.03M
5
PAVMZ
PAVmed Inc. Series Z Warrant
PAVMZ
+$891K

Sector Composition

Rank Sector Weight
1 Healthcare 7.26%
2 Technology 0.29%
3 Financials 0.15%
4 Consumer Discretionary 0.04%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHIP icon
101
Seanergy Maritime Holdings
SHIP
$349M
– –
-312
Closed -$27K
SNES icon
102
SenesTech
SNES
$6.74M
– –
-1
Closed -$27K
TOPS icon
103
TOP Ships
TOPS
$3.6M
– –
-133
Closed -$639K
VKTX icon
104
CALL
Viking Therapeutics
VKTX
$3.88B
– –
-200
Closed -$160K
XNTK icon
105
CALL
State Street SPDR NYSE Technology ETF
XNTK
$1.94B
– –
-385
Closed -$3.66M
TRAW icon
106
Traws Pharma
TRAW
$7.34M
– –
-23,310
Closed -$3.35M
CSCI
107
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-1,020
Closed -$93K
HURA
108
TuHURA Biosciences
HURA
$130M
– –
-701
Closed -$153K
NTBL
109
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-2,294
Closed -$96K
GHSI
110
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
– –
-6,646
Closed -$439K
XBIOW
111
DELISTED
Xenetic Biosciences, Inc. Warrants
XBIOW
– –
-216,789
Closed -$297K
DMK
112
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-2
Closed -$8K
NMTR
113
DELISTED
9 Meters Biopharma
NMTR
– –
-47,079
Closed -$525K
ARQL
114
CALL
DELISTED
Arqule Inc
ARQL
– –
-772
Closed -$1.54M
SPHS
115
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-42,378
Closed -$68K
AIM
116
AIM ImmunoTech
AIM
$6.65M
– –
-5,293
Closed -$288K
1 2 3 4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q1 2020 Portfolio in Review

As of Q1 2020, Sabby Management held 117 positions worth $241M, down 33% from $361M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Sabby Management withdrew a net $12M in Q1 2020, closing 31 positions and reducing 22 holdings. Its most notable exit was Traws Pharma, an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.3% of assets, up from 5.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in State Street Health Care Select Sector SPDR ETF worth $3.05M.

  • Sabby Management's largest Q1 2020 buy was State Street Health Care Select Sector SPDR ETF: 34,410 shares worth $3.05M.
  • Sabby Management added most to Outlook Therapeutics in Q1 2020, an estimated $2.36M increase.
  • Sabby Management's biggest Q1 2020 reduction was SPDR Gold Trust, cutting an estimated $2.92M.
  • Sabby Management fully exited Traws Pharma in Q1 2020, selling an estimated $3.35M.
  • Sabby Management's ten largest holdings make up 82% of its $241M portfolio in Q1 2020.
  • Sabby Management opened 44 new positions and closed 31 in Q1 2020.
  • Sabby Management's portfolio value fell 33% quarter-over-quarter to $241M.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.